Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Preclinical Models of Multiple Sclerosis: Advantages and Limitations towards Better Therapies.
Olfactory Ensheathing Cell Transplantation after a Complete Spinal Cord Transection Mediates Neuroprotective and Immunomodulatory Mechanisms to Facilitate Regeneration.
Frequency of myasthenia gravis in multiple sclerosis: Report of five cases from Isfahan, Iran.
MicroRNAs as Novel Regulators of Neuroinflammation.
No evidence of disease activity in multiple sclerosis: Implications on cognition and brain atrophy.
Transplantation of mesenchymal stem cells in a laryngeal carcinoma patient with radiation myelitis.
Effectiveness of rehabilitation in multiple sclerosis relapse on fatigue, self-efficacy and physical activity.
Feasibility study design and methods for Project GEMS: Guidelines for Exercise in Multiple Sclerosis.
Disability profile of multiple sclerosis in New Zealand.
Response to Comment on "Thiamine Deficiency Promotes T Cell Infiltration in Experimental Autoimmune Encephalomyelitis: The Involvement of CCL2".
A Predictive Model for Corticosteroid Response in Individual Patients with MS Relapses.
Identification of Vulnerable Cell Types in Major Brain Disorders Using Single Cell Transcriptomes and Expression Weighted Cell Type Enrichment.
Decreased Myelinated Fibers in the Hippocampal Dentate Gyrus of the Tg2576 Mouse Model of Alzheimer's Disease.
A novel internet-based method of capturing outcomes in multiple sclerosis.
Optical coherence tomography in the diagnosis and management of optic neuritis and multiple sclerosis.
Selective CB2 receptor activation ameliorates EAE by reducing Th17 differentiation and immune cell accumulation in the CNS.
Targeting semaphorins in MS as a treatment strategy to promote remyelination: A tale of mice, rats and men.
Favorable outcome of granulocyte colony-stimulating factor use in neuromyelitis optica patients presenting with agranulocytosis in the setting of rituximab.
The effect of inflammation and its reduction on brain plasticity in multiple sclerosis: MRI evidence.
New pharmacological approaches against chronic bowel and bladder problems in paralytics.
Childhood obesity and risk of pediatric multiple sclerosis and clinically isolated syndrome.
Increased serum levels of C21 steroids in female patients with multiple sclerosis.
Progressive cerebral atrophy in neuromyelitis optica.
The crystal structure of an integral membrane fatty acid α-hydroxylase.
Cost Offset Analysis of Interferon Beta Disease Modifying Therapies In Relapsing-Remitting Multiple Sclerosis.

Pages